Distinguishing Ulcerative Colitis from Crohn's Disease
Initial Diagnostic Workup
- The European Society of Gastrointestinal Endoscopy recommends performing a complete ileocolonoscopy with multiple biopsies from at least five sites, including ileum and rectum, combined with cross-sectional imaging (MRI or CT enterography) to definitively differentiate between ulcerative colitis and Crohn's disease 1
- Complete ileocolonoscopy is mandatory, even if initial sigmoidoscopy suggests ulcerative colitis, because approximately one-third of Crohn's disease patients have small bowel involvement not detectable by sigmoidoscopy alone 2, 1
- Obtain at least two biopsies from five different sites: terminal ileum, cecum, ascending colon, transverse colon, descending colon, sigmoid colon, and rectum—even from normal-appearing mucosa 2, 1
- Biopsies from unaffected areas are essential to document histologically the spared segments between inflammatory areas, which is characteristic of Crohn's disease 1
- Systematically perform MRI or CT enterography in all patients at diagnosis to evaluate small bowel involvement and exclude complications 1
- This imaging is indispensable because small intestine disease cannot be detected by colonoscopy and strongly suggests Crohn's disease over ulcerative colitis 1
- Obtain complete blood count, CRP, albumin, liver function tests, iron status, renal function, and vitamin B12 1
- Measure fecal calprotectin (sensitivity 93%, specificity 96% for inflammatory bowel disease; optimal threshold 100 μg/g) 1
- Always perform stool cultures and Clostridium difficile toxin assay to exclude infectious mimics before finalizing the diagnosis 2, 3
Key Distinguishing Features
- Ulcerative colitis begins in the rectum and extends proximally in a continuous, uninterrupted pattern with gradually decreasing inflammation severity 4, 1
- Crohn's disease shows patchy, discontinuous distribution with skip lesions throughout the gastrointestinal tract 1
- Rectal involvement is present in >97% of untreated ulcerative colitis cases, whereas rectal sparing is common in Crohn's disease and occurs in only up to 3% of ulcerative colitis patients 2, 1
- Ulcerative colitis: Inflammation limited to mucosa and occasionally submucosa 1
- Crohn's disease: Transmural inflammation affecting all layers of the intestinal wall 1
- Non-caseating granulomas are absent in ulcerative colitis but present in Crohn's disease, serving as a key distinguishing feature 1
- Crypt abscesses are more common in ulcerative colitis (41%) than Crohn's disease (19%) 1
- Ulcerative colitis shows diffuse inflammatory infiltrate without variations in intensity, while Crohn's disease demonstrates variable intensity within and between biopsies 1
- Basal plasmacytosis, diffuse crypt atrophy and distortion, villous surface irregularity, and mucus depletion suggest ulcerative colitis 2
- Primary sclerosing cholangitis is more commonly associated with ulcerative colitis than Crohn's disease 1
Special Diagnostic Challenges
- In 5-15% of cases, endoscopic and histological evaluation cannot distinguish between Crohn's colitis and ulcerative colitis 2, 1
- When initial evaluation is inconclusive, perform capsule endoscopy of the small intestine, which can establish a definitive diagnosis of Crohn's disease by demonstrating small bowel lesions in 17-70% of patients with unclassified inflammatory bowel disease 1
- A negative capsule endoscopy does not definitively exclude a future diagnosis of Crohn's disease 1
- Rectal sparing can occur in ulcerative colitis patients who have received empirical topical therapy, potentially mimicking Crohn's disease 2
- A "cecal patch" (isolated peri-appendiceal inflammation) and backwash ileitis (occurring in up to 20% of extensive colitis) can occur in ulcerative colitis but should prompt small bowel evaluation if other features are atypical 2
- Uneven distribution of inflammation within the colon can occur in ulcerative colitis patients with long-standing disease or after treatment 2